Saamya Biotech

Saamya_Biotech13 Aug 2018

Pharmaceuticals

₹

0.00 (0.00%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Saamya Biotech

Saamya Biotech

Pharmaceuticals

Saamya_Biotech13 Aug 2018

₹

0.00 (0.00%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
11-Jul-2022	BC	Trading Members of the Exchange are hereby informed that the undermentioned 37 companies that have remained suspended for more than 6 months would be delisted from the platform of the Exchange, with	13-Jul-2022
14-Aug-2019	BC	With reference to the subject cited, this is to inform the Exchange that meeting of the Board of Directors of Saamya Biotech (India)Limited will be held on Monday, the 14th day of August, 2019, at 4.	14-Aug-2019
28-Aug-2018	BC	This is in continuation to Exchange Notice No. 20180201-30 dated February 1, 2018 wherein the Trading Members were advised that w.r.t to the following companies, 15 days after suspension had been eff	11-Sep-2018
01-Feb-2018	BC	Pursuant to the provisions of Circular no. CIR/CFD/CMD/12/2015 dated November 30, 2015 issued by Securities and Exchange Board of India (SEBI) with respect to Standard Operating Procedure (SOP) for s	23-Feb-2018
09-Sep-2017	BC	Saamya Biotech India Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 23, 2017 to September 29, 2017 (both days inclusive) for	29-Sep-2017

No Rights has been declared by Saamya_Biotech

Book Closure

Record Date	Split Date	Purpose
13-Jul-2022	-	Trading Members of the Exchange are hereby informed that the undermentioned 37 companies that have remained suspended for more than 6 months would be delisted from the platform of the Exchange, with
14-Aug-2019	-	With reference to the subject cited, this is to inform the Exchange that meeting of the Board of Directors of Saamya Biotech (India)Limited will be held on Monday, the 14th day of August, 2019, at 4.
11-Sep-2018	-	This is in continuation to Exchange Notice No. 20180201-30 dated February 1, 2018 wherein the Trading Members were advised that w.r.t to the following companies, 15 days after suspension had been eff
23-Feb-2018	-	Pursuant to the provisions of Circular no. CIR/CFD/CMD/12/2015 dated November 30, 2015 issued by Securities and Exchange Board of India (SEBI) with respect to Standard Operating Procedure (SOP) for s
29-Sep-2017	-	Saamya Biotech India Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 23, 2017 to September 29, 2017 (both days inclusive) for

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Saamya Biotech (India) Ltd ₹1.97(0.00/0.00%)	1.97	+0.00	4.90	5.35	0.00	-0.37
Astrazeneca Pharma India Ltd ₹5,556.10(+140.70/2.60%)	5,556.10	+140.70	13,890.25	71.09	87.09	21.21
Bliss GVS Pharma Ltd ₹124.45(+1.85/1.51%)	124.45	+1.85	1,302.88	60.79	19.09	1.33
Cipla Ltd ₹1,407.55(-1.85/-0.13%)	1,407.55	-1.85	113,644.88	54.54	34.56	4.39
Abbott India Ltd ₹26,277.60(+412.75/1.60%)	26,277.60	+412.75	55,839.90	15.87	48.74	17.96
Amrutanjan Health Care Ltd ₹709.40(+28.55/4.19%)	709.40	+28.55	2,050.92	13.21	46.61	7.83

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Jun 19	Mar 19	Dec 18	Sep 18	Jun 18	Mar 18
Gross Sales	0.00	0.00	0.00	0.00	0.00	0.00
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	0.00	0.00	0.00	0.00	0.00	0.00
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.00	0.00	0.00	0.00	0.00	0.00
Total Income	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	0.01	0.01	0.00	0.01	0.01	0.01
PBIDT	-0.01	-0.01	0.00	-0.01	-0.01	-0.01
Interest	0.00	0.00	0.00	0.00	0.00	0.00
PBDT	-0.01	-0.01	0.00	-0.01	-0.01	-0.01
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Profit After Tax	-0.01	-0.01	0.00	-0.01	-0.01	-0.01
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	-0.01	-0.01	0.00	-0.01	-0.01	-0.01

EPS (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
EPS (Adj) (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Calculated EPS (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Calculated EPS (Adj) (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Calculated EPS (Ann.) (Unit Curr.)	-0.01	-0.01	0.00	-0.01	-0.01	-0.02
Calculated EPS (Adj) (Ann.) (Unit Curr.)	0.00	0.00	0.00	0.00	-0.01	-0.02
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	24.88	24.88	24.88	24.88	24.88	24.88
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	0.00	0.00	0.00	0.00	0.00	0.00
PBDTM(%)	0.00	0.00	0.00	0.00	0.00	0.00
PATM(%)	0.00	0.00	0.00	0.00	0.00	0.00

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 16	Mar 15	Mar 14	Mar 13	Mar 12	Mar 11
SOURCES OF FUNDS :
Share Capital	24.88	24.88	24.88	24.88	24.88	23.09
Reserves Total	3.37	3.81	4.49	4.40	4.80	0.11
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	6.20
Equity Application Money	0.00	0.00	0.00	4.38	3.90	2.51
Total Shareholders Funds	28.25	28.69	29.37	33.66	33.58	31.91
Secured Loans	0.00	0.00	0.12	0.15	0.16	0.20
Unsecured Loans	3.24	3.63	4.31	0.20	0.22	0.02
Total Debt	3.24	3.63	4.43	0.35	0.38	0.22
Total Liabilities	31.49	32.32	33.80	34.01	33.96	32.13
APPLICATION OF FUNDS :
Gross Block	11.65	11.85	12.09	1.56	1.64	1.42
Less : Accumulated Depreciation	2.11	1.19	0.29	0.18	0.12	0.05
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	9.54	10.66	11.80	1.38	1.52	1.37
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	18.25	18.25	18.25	29.34	29.02	28.75
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	0.00	0.00	0.00	0.00	0.00	0.00
Sundry Debtors	50.18	43.17	13.16	21.01	18.36	8.18
Cash and Bank	0.02	0.02	0.02	0.01	0.04	0.04
Loans and Advances	0.65	0.65	1.17	1.17	1.51	1.25
Total Current Assets	50.85	43.84	14.35	22.19	19.91	9.47
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	46.88	39.91	10.09	19.02	16.21	7.25
Provisions	0.95	0.70	0.65	0.10	0.51	0.41
Total Current Liabilities	47.83	40.61	10.74	19.12	16.72	7.66
Net Current Assets	3.02	3.23	3.61	3.07	3.19	1.81
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.50	0.05	0.24	0.00	0.00	0.00
Deferred Tax Liability	-0.02	0.03	0.27	0.00	0.01	0.04
Net Deferred Tax	0.52	0.02	-0.03	0.00	-0.01	-0.04
Total Assets	31.33	32.16	33.63	33.79	33.72	31.89
Contingent Liabilities	0.20	0.20	0.00	0.00	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012
Cash and Cash Equivalents at Beginning of the year	0.02	0.02	0.00	0.04	0.04
Net Cash from Operating Activities	0.08	0.62	-0.22	-0.19	-1.01
Net Cash Used In Investing Activities	0.31	0.17	0.50	-0.29	-0.51
Net Cash Used In Financing Activities	-0.39	-0.80	-0.27	0.45	1.52
Net Inc./Dec In Cash And Cash Equivalents	0.00	0.00	0.01	-0.03	0.00
Cash And Cash Equivalents At End Of The Year	0.02	0.02	0.01	0.01	0.04

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

25.62%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

74.38%

**Promoter pledged shareholding 25.62%

About Saamya Biotech (India) Ltd

Saamya Biotech (India) Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 4.9 crores. It has reported a sales of Rs. 0 crores and a net profit of Rs. -0.01 crores for the quarter ended December 2018. The company management includes , Y Manivardhan Reddy,Y Sonia Reddy,P Naveen Chander Reddy,P Suresh Reddy,Santosh Jagannath Sawant (Saamya Biotech (India) Ltd) among others.

Chairman

Registered office

Flat No 104-106 Lumbini Enclav,Panjagutta,Hyderabad,Telangana,500082

FAX :91-40-23397099

Background

Incorporation Year2002

Face Value₹10

Market Lot1

How to buy Saamya Biotech shares on nse?

To buy Saamya Biotech shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Saamya Biotech share price today?

The Saamya Biotech shares price on nse is Rs.1.97 today.

What is the market cap of Saamya Biotech shares on BSE ?

The company has a market capitalization of Rs.4.90Cr

What is the PE & PB ratio of Saamya Biotech shares ?

PE is 0 and PB is -0.37

What is the 52 Week High and Low of Saamya Biotech shares?

Saamya Biotech stock price high: Rs.2.07 Saamya Biotech stock price low: Rs.0